Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07846033 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase 1 Study of VK3019 in Overweight and Obese Adults Without Comorbidities

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 29, 2026 (before its estimated October 2, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This is a Phase 1, randomized, double-blind, placebo-controlled single ascending dose (SAD) study to evaluate the safety, tolerability, pharmacodynamics and pharmacokinetics of VK3019 in overweight and obese adults without comorbidities.
Trial Details
NCT Number NCT07846033
Lead Sponsor Viking Therapeutics, Inc.
Conditions
(from sponsor)		 Obese Adults
Related terms Weight Loss
Enrollment 56 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov